Ponvory 7 MG Oral Tablet

RxCUI
2532341
RxNorm name
Ponvory 7 MG Oral Tablet
Display name
Ponvory 7 MG Oral Tablet
Full name
Ponvory 7 MG Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:00

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
5be69660-738c-4db7-b0d4-517aa873dc41Ponvory 7 MG Oral TabletSY13These highlights do not include all the information needed to use PONVORY safely and effectively. See full prescribing information for PONVORY. PONVORY ® (ponesimod) tablets, for oral use Initial U.S. Approval: 202120250425
5be69660-738c-4db7-b0d4-517aa873dc41Ponvory 7 MG Oral TabletPSN13These highlights do not include all the information needed to use PONVORY safely and effectively. See full prescribing information for PONVORY. PONVORY ® (ponesimod) tablets, for oral use Initial U.S. Approval: 202120250425
5be69660-738c-4db7-b0d4-517aa873dc41ponesimod 7 MG Oral Tablet [Ponvory]SBD13These highlights do not include all the information needed to use PONVORY safely and effectively. See full prescribing information for PONVORY. PONVORY ® (ponesimod) tablets, for oral use Initial U.S. Approval: 202120250425
0c025ba8-ba51-272e-e063-6294a90ad120Ponvory 7 MG Oral TabletSY4These highlights do not include all the information needed to use PONVORY safely and effectively. See full prescribing information for PONVORY. PONVORY ® (ponesimod) tablets, for oral use Initial U.S. Approval: 202120251204
0c025ba8-ba51-272e-e063-6294a90ad120Ponvory 7 MG Oral TabletPSN4These highlights do not include all the information needed to use PONVORY safely and effectively. See full prescribing information for PONVORY. PONVORY ® (ponesimod) tablets, for oral use Initial U.S. Approval: 202120251204
0c025ba8-ba51-272e-e063-6294a90ad120ponesimod 7 MG Oral Tablet [Ponvory]SBD4These highlights do not include all the information needed to use PONVORY safely and effectively. See full prescribing information for PONVORY. PONVORY ® (ponesimod) tablets, for oral use Initial U.S. Approval: 202120251204